Markets:

Overview

News

Currencies

International

Treasuries

Sagimet Biosciences Inc. - Series A Common Stock (NQ:SGMT)

5.712 -0.368 (-6.05%)

Streaming Delayed Price Updated: 12:20 PM EST, Feb 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Sagimet Biosciences Inc. - Series A Common Stock

< Previous 1 2 Next >

Tuesday's session: gap up and gap down stocks ↗

February 03, 2026

Via Chartmill

Get insights into the top gainers and losers of Thursday's after-hours session. ↗

January 08, 2026

Via Chartmill

Sagimet Biosciences Stock Soars After Positive Data For Experimental Drug In Acne Study ↗

October 24, 2025

Via Stocktwits

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

October 22, 2025

Via Benzinga

Sagimet Biosciences Tops Q2 EPS Forecast ↗

August 13, 2025

Via The Motley Fool

This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday ↗

July 24, 2025

Via Benzinga

Here are the top movers in Thursday's session. ↗

June 12, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 12, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

June 04, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps ↗

June 04, 2025

Denifanstat showed positive Phase 3 results in acne, meeting all goals with strong safety, as Sagimet pushes ahead with a second FASN inhibitor trial.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 04, 2025

Via Benzinga

The market is filled with gapping stocks in Monday's session. ↗

April 21, 2025

The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

January 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 16, 2024

Via Benzinga

Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket ↗

December 16, 2024

Via Benzinga

This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

November 12, 2024

Via Benzinga

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH ↗

November 01, 2024

Madrigal sells an approved MASH treatment that blasted third-quarter sales views out of the water.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 01, 2024

Via Benzinga

SGMT Stock Earnings: Sagimet Biosciences Beats EPS for Q2 2024 ↗

August 14, 2024

SGMT stock results show that Sagimet Biosciences beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

What's Going On With Sagimet Biosciences Stock On Thursday? ↗

June 06, 2024

Sagimet Biosciences shared promising data from its FASCINATE-2 Phase 2b trial of denifanstat at the EASL Congress.

Via Benzinga

What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday? ↗

June 05, 2024

Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment....

Via Benzinga

Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday ↗

May 16, 2024

Via Benzinga

SGMT Stock Earnings: Sagimet Biosciences Beats EPS for Q1 2024 ↗

May 15, 2024

SGMT stock results show that Sagimet Biosciences beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 25, 2024

Via Benzinga

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? ↗

March 17, 2024

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 16, 2024

Via Benzinga

Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 06, 2024

Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 06, 2024

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.